OPEN Health

What OPEN Health does

OPEN Health is a global scientific communications and strategic consulting partner to the biopharmaceutical industry, operating as a private limited liability partnership registered in England and Wales with headquarters in London. The company serves approximately 200 global pharmaceutical clients through an integrated platform of five service lines: HEOR and market access (via the OPEN Pharmerit entities, including health economics modeling, real-world evidence analytics, pricing strategy, and patient-centered outcomes research); scientific communications (medical affairs strategy, publications planning, MSL content); creative communications (internal/external communications, disease awareness, animation, and patient programs); consulting through Acsel Health (commercial strategy from early development through market maturity); and patient engagement, anchored by the proprietary Patient Engager™ program that combines advocacy engagement, health psychology, behavior science, and patient storytelling.

The company's technology stack is built around four AI-augmented capabilities: AI-powered systematic literature reviews and evidence synthesis for HEOR and EU HTA Joint Clinical Assessments; a proprietary tokenized data platform for real-world evidence generation that preserves data privacy; generative AI tooling for scientific content creation; and AI readiness frameworks published in ISPOR's Value & Outcomes Spotlight. They rely on a combination of proprietary workflows and third-party AI platforms (Fusion, Artefact, Triradial, ELO AI, Nested Knowledge). The 1,100-person workforce is distributed across the UK, US, China, the Netherlands, Germany, and India through a multi-entity corporate structure comprising 18 wholly-owned subsidiaries.

OPEN Health generates revenue through professional services engagements (project-based and retainer) sold via direct enterprise sales to biopharmaceutical companies. The GTM motion is sales-led, with services scoped per client product lifecycle from early development through market maturity. Pricing is bespoke and not publicly disclosed. The company has won 47 industry awards since 2019 across categories including animation, internal communications, patient programs, market access, and medical affairs. Ownership is private; no parent company or institutional investor was identified in the source materials, though the multi-entity roll-up structure and acquisition history (The CM Group in July 2022, Acsel Health in February 2023) are characteristic of a PE-backed platform.

Name

OPEN Health

Legal name

OPEN Health Communications LLP

Website

https://openhealthgroup.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

1–10 employees

Short description

OPEN Health is a global scientific communications, HEOR, market access, consulting, and patient engagement services firm that partners with approximately 200 pharmaceutical companies across the UK, US, Europe, China, and India through a 1,100-person workforce and AI-augmented evidence-generation capabilities.

Ownership category

akta.pro rank

Product category

Healthcare Communications & Consulting

NAICS

Offices of Other Health Practitioners (6213)

SIC

Services-Misc Health & Allied Services, Nec (8090), Services-Health Services (8000)

akta.pro primary industry

Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG)

akta.pro secondary industries

Healthcare/Pharma Creative Agencies (MPAAAAAJ), Healthcare & Life Sciences PR (MPAAADAD)

Keywords

• Medical communications services
• Health economics research
• Market access consulting
• Patient engagement solutions
• Scientific communications strategy

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices9 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Professional Services - HEOR & Market Access: Health economics and outcomes research (HEOR) services including strategic market access, modeling and meta-analysis, real-world evidence and data analytics, and patient-centered outcomes research provided to biopharmaceutical clients.
2. Scientific & Medical Communications: Medical communications, scientific communications, publications planning and delivery, MSL strategy and content, and medical affairs strategy services for pharmaceutical clients.
3. Consulting (Acsel Health): Strategic consulting services combining deep industry expertise and scientific rigor to guide life-changing innovations from early development through market maturity.
4. Patient Engagement Services: Strategic patient innovation and engagement solutions, patient support programs, and patient advocacy group collaboration services.
5. Creative Communications: Creative communications services including animation, film, external communications, and internal communications for pharma clients.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

OPEN Health is a global professional services firm delivering medical communications, health economics and outcomes research (HEOR), market access, strategic consulting, and patient engagement services to biopharmaceutical clients. Its five interconnected service lines — Acsel Health consulting, HEOR & Market Access, Scientific Communications, Creative Communications, and Patient Engagement — guide life-changing innovations from early development through market maturity. The firm employs approximately 1,100 people across the UK, US, Europe, China, and India, serving 200 global pharmaceutical clients.

Product overview

OPEN Health is a global scientific communications and strategic consulting partner to the biopharmaceutical industry, offering an integrated platform of specialized services. The portfolio centers on five interconnected service lines: (1) Acsel Health consulting for commercial and strategic guidance from early development through market maturity; (2) HEOR & Market Access providing health economics, outcomes research, pricing strategy, and real-world evidence analytics; (3) Scientific Communications delivering medical affairs strategy, publications planning, and MSL content; (4) Creative Communications spanning internal/external communications, disease awareness, and patient programs; and (5) Patient Engagement including the proprietary Patient Engager™ program, advocacy engagement, health psychology, and patient content. These services work together to connect evidence generation, medical strategy, market access, scientific communications, and stakeholder engagement across the product lifecycle.

Differentiator

Problem solved

Functional benefit

Products and services

• Consulting (Acsel Health)

Quantifiable outcome

• Served 200 global pharmaceutical clients
• +1 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature4 records

Partnerships

One partnership is on record.

• Exponential-e LimitedcoreTechnology or IntegrationExponential-e Limited is an accredited provider of IT Managed Services operating OPEN Health's core information technology systems. They provide 24x7x365 cyber security operation centre (CSOC) monitoring, network hardening, and security services including VPN, Secure Web, and Data Loss Prevention (DLP) capabilities.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Fishawack Health: Specialist medical communications, HEOR, and market access agency serving biopharma clients globally. Fishawack competes head-to-head with OPEN Health across scientific communications, publications, and value communications mandates.
• Avalere Health: HEOR, market access, and patient engagement consultancy serving life sciences companies. Directly comparable to OPEN Health's Evidence & Access and Patient Engagement practices across similar client segments and service lines.
• Lumanity: HEOR, market access, medical affairs, and patient evidence consultancy formed through the merger of several specialist agencies. Directly competes with OPEN Health across HEOR, real-world evidence, and value communications services.
• Real Chemistry: Healthcare marketing, communications, and patient engagement agency serving biopharma clients. Comparable to OPEN Health's creative communications and patient engagement practices with similar customer base.
• Beghou Consulting: Specialist life sciences consulting firm focused on commercial, market access, and analytics for biopharma. Overlaps directly with OPEN Health's Acsel Health consulting and HEOR & Market Access practices.
• Inizio Medical: Medical communications and scientific engagement platform formed through multiple agency roll-ups. Directly competes with OPEN Health's scientific communications, publications, and medical affairs service lines across similar biopharma clients.

Broad incumbents

• IQVIA: Global leader in clinical research, HEOR, real-world evidence, and commercial services for life sciences. While broader in scope, IQVIA competes with OPEN Health in HEOR, market access, and scientific communications as part of a much larger integrated portfolio.
• Eversana: Independent life sciences commercial services firm offering market access, HEOR, patient services, and medical communications. Competes with OPEN Health across multiple service lines but operates at significantly larger scale and broader scope.
• ZS Associates: Global management consulting firm with a dedicated life sciences practice spanning commercial, R&D, and evidence generation. Competes with OPEN Health's consulting (Acsel Health) and HEOR practices as part of a much broader consulting portfolio.
• Parexel: Global CRO offering clinical development, regulatory, HEOR, and market access services. Overlaps with OPEN Health in HEOR and medical communications as part of full-service clinical and commercial offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/OPENHealth
• Facebookfacebook.com/openhealthgroup
• LinkedInlinkedin.com/company/open-health
• Instagraminstagram.com/weareopenhealth

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries18 records

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OPEN Health